Contexium

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 28 Apr 2027. The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent a…

Opportunity overview

Project name
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support...

Frequently asked questions

What is NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)?

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 28 Apr 2027. The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent a…

Who is funding NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)?

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) is funded by National Institutes of Health.

When is the deadline to apply for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)?

The application deadline is 28 Apr 2027 00:00 (UTC).

Where will the NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) project take place?

The project location(s) are: United States.

How can I apply for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.